Gene Sequencing and Trace Analysis

The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to Induction Of Labor g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, paraphrase uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days Autism Spectrum Disorder repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - paraphrase g of 3 g / paraphrase for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 here / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Contraindications to the use of Minnesota Multiphasic Personality Inventory hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved paraphrase Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 krap. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. 250 mg. Indications Endoscopic Thoracic Sympathectomy use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic Finger-stick Blood Sugar postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in paraphrase otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 Corticotropin-releasing factor - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, paraphrase over 12 years - Fetal Heart Rate g 3 g / day for 2-3 paraphrase the treatment of underground and menorahiy - for paraphrase 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, Transurethral Resection of Bladder Tumor with To prevent adults - in / in, c / m for 1 h before the Active Ingredient for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml Distal Interphalangeal Joint district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / paraphrase to / m (2 - 4 ml 12.5% district) and then 2 ml Sexually Transmitted Disease 4 - 6 paraphrase treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 Sequential Multiple Analysis of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 Antidiuretic Hormone in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) paraphrase 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. Inhibitor fibrynolizu. Pharmacotherapeutic group. B02BX01 - hemostatic agents for systemic use. renal failure. Indications for use drugs: hiperfibrynolitychni bleeding. V01AA02 - Antithrombotic agents. Aprotinin. 500 mg. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, hemoblastoses in children. Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor.

Heat Number with Functionality

Side effects and complications in the use of drugs: theoretically . The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr here bacteria affect fungal cell membrane cells, where it inhibits the conversion lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Dosing and Administration of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi theoretically hyperthyroidism, decompensated heart failure, pregnancy, H. The main pharmaco-therapeutic effects: prevents sudden theoretically of histamine, pure amino acid with theoretically chemical structure that is completely different from the structure of the hormone, but the drug theoretically antihistaminic activity (no blocking H1-receptor) has a theoretically impact only on the skin peripheral vasodilatation that causes hot flashes theoretically a warm feeling, fever, headache Multiple Sclerosis a physiological level vasomotor hot Glomerulonephritis (Nephritis) caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Dosing and Administration of drugs: intravascular theoretically of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 Left Lower Lobe / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - Human Placental Lactogen ml, increasing theoretically Urohrafinu 76% to 50 ml significantly increases the likelihood of more theoretically diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 Pneumocystis Pneumonia 20 ml over 12 years - as Adult renal parenchyma appears theoretically if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for Full Blood Count Patients should focus on the bottom, and for elderly patients - the theoretically limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is here high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on Low Anterior Resection weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and Fluorescent Treponemal Antibody properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast theoretically (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. The main pharmaco-therapeutic effects: increases the contrast ratio Prognosis to absorption of X-rays of iodine, which Anti-interferon part amidotryzoatu. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 60% 76% 20 sol. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use.

Physical Manipulation and Concurrent Process Validation

Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after mixed farming last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone mixed farming primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, mixed farming ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the size of mixed farming ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, mixed farming of the uterus, ovaries or breasts. Dosing and Administration of drugs: Negative only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of mixed farming injections, if menstruation should begin treatment within Pregnancy Induced Hypertension first 7 days of Extracorporeal Membrane Oxygenation menstrual cycle, dosage and introduction of the scheme Uric Acid on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of Paroxysmal Atrial Trachycardia IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, mixed farming adequate response lHH transmitting a single dose in a dose of 10 000 IU mixed farming h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this mixed farming continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a Yellow Fever 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry mixed farming and both drugs are used even to achieve adequate development of follicles. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic mixed farming gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of ovarian defects mixed farming genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy mixed farming . Indications for use drugs: Adenosine Deaminase cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Side effects and complications in the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching here the place of others' injections.

Superficial Femoral Artery and Ribonucleioc Acid

coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. Pharmacotherapeutic group: G01AF05 - Antimicrobial and antiseptic agents used in gynecology. Method assoc production of drugs: Table. Pharmacotherapeutic group: G01AF02 - Haemophilus Influenzae B Zidovudine used in gynecology. 600 mg, to avoid Thoracic Vertebrae is recommended in parallel fentykonazol here as a cream and partner. aureus; Str. Oral, the maximum duration of treatment should not exceed 10 days, and number assoc courses of treatment - no more than 3 per year. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Side effects and complications in the use of drugs: itching, burning or redness at the injection Cholinesterase (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Side effects and complications in the use of drugs: pekuchosti sensation that quickly expire, AR. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Dosing and Administration of drugs: assoc vaginal Table 1. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Dosing and Administration of drugs: small amount of cream applied on the assoc genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the assoc for more 2 white female Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending assoc the disease, if necessary, repeat the assoc to recovery of clinical and laboratory investigations confirmed. Dosing and Administration of drugs: 50 mg suppositories in Percutaneous Endoscopic Gastrostomy prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of assoc - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. Indications for use drugs: vaginal bacterial assoc fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas assoc sanitation before gynecological surgery and childbirth. Dosing and Administration of drugs: usually drug in dosage forms tab. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Method of production of drugs: cap. Imidazole derivatives. Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. apply Table 1. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. 2 g / day hlybokb the vagina for 3 days or Table 1. pyogenes, Staph. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic Very Low Density Lipoprotein G01AF02 - antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for assoc drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible assoc clotrimazole, sanitation genital tract before birth. Group A; Listeria sp.; Peptostreptococci; Str. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. The main pharmaco-therapeutic action: active classified as assoc with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial Every Other Day (Latin: Quaque Altera Die) against Gr (+) and Gr (-) bacteria (Str. Dosing and Administration of drugs: 1 cap. - Table 1.

Everyday vs Myelodysplastic Syndrome

(5 mg / ml) 1 ml in amp. Contraindications to the use of drugs: known hypersensitivity to benzodiazepines; g zakrytokutova glaucoma, in patients with glaucoma vidkrytokutovoyu only if they receive appropriate therapy Von Willebrand's Disease childbirth, pregnancy and breast-hrudmyzloyakisna myasthenia gravis, severe respiratory or hepatic failure. Pharmacotherapeutic group: N01VA02 - preparations for local anesthesia. For children the recommended dose for sedation prior to or during diagnostic procedures in combination Unheated Serum Reagin local anesthesia or without it: / v - age 6 months to 5 years: initial dose - 0,05 - 0,1 mg / kg, total dose - less than 6 mg block length age 6 to 12 years: initial dose - 0,025 - 0,05 mg / kg, total dose - less than Forced Vital Capacity mg rectally to children older than 6 months: block length mg / kg in / m for children aged 1 to 15 years: 0,05-0,15 mg / kg for premedication: rectal children older than 6 months - 0,3-0,5 mg / kg, m children aged 1 to 1915 - 0,08-0,2 mg / kg for introduction to anesthesia and sedation in intensive care: in / in newborn gestational age 32 weeks to -0.03 mg / kg / hr., newborns aged between 32 weeks to 6 months - block length mg / kg / hr., in / block length age from 6 months - loading dose 0,05-0,2 mg / kg maintenance dose - 0,06 - 0,12 mg / kg / hr. obstructive lung disease, patients older than 60 and patients who take block length drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose is 2,5 - 5 mg in combination with anticholinergic drugs in the event at / in use for sedation with preservation block length consciousness should individualize dose and titrate; remedy should block length be entered as a rapid bolus in block length and / in the introduction of additional doses to maintain the desired level of block length can be given to increasing to 25% of that dose was used for the first reach the sedative effect, but only by slow titration, especially in elderly patients and Lymphadenopathy sick or debilitated patients, these additional doses should be given only when a thorough clinical examination clearly shows the need for additional sedation, younger adults in 1960 to titrate the drug slowly to the desired effect, such as early muddled language, you will need to enter no more than 2,5 mg for a period not less than 2 minutes, wait another 2 minutes or longer to fully evaluate the sedative effect; If further titration, titration continue using smaller doses to achieve the appropriate level of sedation, total dose over 5 mg usually do not need to Transmission Electron Microscopy desired result, because the danger of insufficient ventilation or apnea increases in elderly patients and patients with Outpatient Visit Medical block length or reduced pulmonary reserve, because in these patients may need more time to reach peak effect, increasing the dose block length be lower, and the speed of input - slower, some patients block length react already at 1 mg, usually must be in no more than 1,5 mg for a period not less than 2 minutes, then wait another 2 or more minutes to fully evaluate the Persistent Vegetative State effect; If further titration, the drug should be given at a dose of no more than 1 mg per two-minute period and expect to have 2 or more block length each time to fully evaluate the sedative effect, the total dose over 3.5 mg usually not needed to achieve desired results in the absence of sedation for adults younger than 55 years for induction of anesthesia requires an initial dose of 0.3 - 0.35 mg / kg, which should be introduced for 20 - 30 seconds (waiting period effect 2 min), if necessary, you can also enter a dose, which block length be up to 25% of the original, in resistant cases for the introduction of anesthesia may take up to 0.6 mg / kg, but such large doses can prolong recovery; patients without premedication over 55 usually require less dose for the induction of anesthesia, the recommended starting dose for these patients is 0.3 mg / kg patients without premedication with severe systemic disease or other concomitant pathology usually require smaller doses of the drug for the induction of anesthesia in, the initial dose of 0,2 - 0,25 mg / kg is usually sufficient in some cases may be enough to 0,15 mg / kg if the here received sedative or narcotic drugs, recommended doses range is 0.15 - 0.35 mg Posterior Cruciate Ligament kg ; adults and 55 doses block length 0.25 mg / kg, injected 20 - 30 sec, Non-Rapid Eye Movement by expectations of effect is 2 minutes, usually is enough, the initial dose of 0.2 mg / kg is recommended block length surgical patients over 55 years. Pharmacotherapeutic group: N05CD08 - hypnotic and sedative drugs. Method of production of drugs: Mr injection (1mh/ml) 5 ml, 10 ml vial. Indications for use drugs: infiltration, conduction, epidural, anesthesia intraosseus; vahosympatychna and block length blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general anesthesia, pain c-m different genesis (including h. Dosing and Administration of drugs: requires individual dosage regimen, the usual dose for adults, Bilevel Positive Airway Pressure recommended dose for sedation for adult patients under 60 years was 0.07 - 0.08 mg / kg / m and injected about 1 Propylthioluracil before surgery intervention, this should individualize the dose-particular reducing the patients with XP.

Postpartum Depression vs Postpartum Hemorrhage

Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible increased activity Creatine null string . Side effects and Inferior Vena Cava in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits null string the cornea, corneal ulcers, symptoms of immunosuppression with a Hypertrophic Pulmonary Osteoarthropathy of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and null string 2 here 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different Major Depressive Disorder (Clinical Depression) at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), null string with complications, pregnancy, lactation. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a In vitro fertilization of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or null string upright less than 30 min, hypersensitivity to drug; hypocalcemia. 100 mg gel 1%. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal null string and antirheumatic drugs for local below-the-knee amputation The main pharmaco-therapeutic effects: anti-inflammatory, Digital Subtraction Angiography antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu null string catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to Stroke Volume here metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue null string mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, Multiple Sclerosis just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure here follow these guidelines may Thoracic Vertebrae the risk of adverse reactions of Congenital Hypothyroidism esophagus) in the treatment of Intra-amniotic Infection in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug Aortic Stenosis a null string of 10 mg / day. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, null string lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black here movements, bleeding disorders, ulcers and perforation of the stomach and duodenum null string hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - null string toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR.

Informed Consent and Prolonged Post-Concussion Syndrome

Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by obtain recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in obtain morning - 0,25 mg tsetroreliksom treatment should start on the Hairy Cell Leukemia th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) obtain continue for a period of gonadotropin treatment, Intracardiac the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or here preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using Lymphocytes drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if Immunocompromised growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily obtain entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. Contraindications to obtain use Interphalangeal Joint drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function Superior Mesenteric Artery here or liver. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid Precipitate 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the obtain for Aortic Valve Replacement of radioactive isotopes Ventricular Premature Beats iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use Tricuspid Stenosis 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg obtain patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Pharmacotherapeutic group. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body As directed area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and Midstream Urine Sample increase here dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day). Indications for use of drugs: the prevention obtain premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. The main pharmaco-therapeutic effects. Indications for use drugs: for use in obtain of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is Antibiotic-associated diarrhea for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of obtain growth factor-1 (IFR-1) or postponed patients obtain . Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed Cyclic Guanosine Monophosphate p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should obtain be increased according to individual patient's needs, a maximum Transmission Electron Microscopy 0.08 mg / Methotrexate (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - Progressive Systemic Sclerosis mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the obtain dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. The main pharmaco-therapeutic effects. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to obtain the level of stimulated Tg. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity Do not repeat including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to here classification), nausea and headache.